Determination of endotoxin-neutralizing capacity of plasma in postsurgical patients

European Surgical Research

Volumn 28, Issue 2, 1996, Pages 130-139

  Berger, D ^a   Ott, Susanne ^a   Schmidt, Uta Maria ^a   Bolke E ^a   Seidelmann, Manuela ^a   Beger, H G ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Endotoxin; Endotoxin neutralizing capacity; Organ failure; Plasma

Indexed keywords

DIURETIC AGENT; ENDOTOXIN;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; GOITER; HUMAN; KIDNEY FUNCTION; LAPAROTOMY; LIMULUS LYSATE TEST; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PNEUMONIA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

EID: 0030056936     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000129450     Document Type: Article

References (38)

1. Berger D, Beger HG: Evidence for endotoxin binding capacity of human Ge-globulin and transferrin. Clin Chim Acta 1987:163:289-299.
2. Berger D, Winter M, Beger HG: Influence of human transferrin and group-specific protein on endotoxicity in vitro. Clin Chim Acta 1990: 189:1-5.
3. Berger D. Schleich S. Seidclmann M, Beger HG: Demonstration of an interaction between transferrin and lipopolysaccharide - An in vitro study. Eur Surg Res 1991:23:309-316.
4. Berger D, Beger HG: Interaction of endotoxin and endotoxin-binding proteins. Postgrad Surg 1991:3:174-181.
5. Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW: Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J Immunol 1990;144:662-666.
6. Larrick JW, Hirata M, Zheng H, et al: A novel granulocyte-derived peptide with lipopolysaccharide-neu-tralizing activity. J Immunol 1994: 152:231-240.
7. Marra MN, Thornton MB, Snable JL. Wilde CG, Scott RW: Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5. Cril Care Med 1994:22:559-565.
8. Wright SD, Ramos RA, Hermanowski Vosatka A, Rockwell P, Detmers PA: Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: Dependence on lipo-polysaccharidc binding protein and CDI4. J Exp Med 1991:173:1281-1286.
9. Hailman E, Lichtenstein HS, Wurlel MM, et al: Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD 14. J Exp Med 1994;179:269-277.
10. Gallay P, Heumann D, Le Roy D, Barras C, Glauser MP: Lipopolysac-charide-binding protein as a major plasma protein responsible forendo-toxcmic shock. Proc Natl Acad Sci USA 1993;90:9935-9938.
11. Dentener MA, Von Asmuth EJ, Francot GJ, Marra MN, Buurntan WA: Antagonistic effects of lipo-polysaceharidc binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. J Immunol 1993:151:4258-4265.
12. Munford RS, Hall CL: Purification of acyloxyacyl hydrolase, a leukocyte enzyme that removes secondary acyl chains from bacterial lipopoly-saccharidcs. J Biol Chem 1989:264: 15613-15619.
13. Erwin AL, Munford RS: Déacylation of structurally diverse lipopoly-saccharidcs by human acyloxyacyl hydrolase. J Biol Chem 1990:265: 16444-16449.
14. Erwin AL, Munford RS: Plasma lipopolysaccharide-deacylaling activity (acyloxyacyl hydrolase) increases after lipopolysaccharide administration to rabbits. Lab Invest 1991:65: 138-144.
15. Munford RS, Hunter JP: Acyloxyacyl hydrolase, a leukocyte enzyme that dcacylates bacterial lipopoly-saccharides, has phospholipasc, lysophospholipase, diacylglycerol lipase, and acyltransfcrasc activities in vitro. J Biol Chem 1992:267: 10116-10121.
16. Rail DP, Gaskins JR, Kelley MG: Reduction of febrile response to bacterial polysaccharide following incubation with scrum. Am J Physiol 1957;188:559-562.
17. Rudbach JA, Johnson AG: Restoration of endotoxin activity following alteration by plasma. Nature 1964; 202:811-812.
18. Flegel WA, Woelpl A, Macnnel DN, Northoff H: Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect Immun 1989;57:2237-2245.
19. Olofsson P, Olofsson C, Nylander G, Olsson P: Endotoxin inactivation in plasma from septic patients: An in vitro study. World J Surg 1986; 10:318-323.
20. Warren HS, Novitsky TJ, Ketchum PA, Roslansky PF, Kania S, Siber GR: Neutralization of bacterial lipo-polysaccharidcs by human plasma. J Clin Microbiol 1986:22:590-595.
21. Warren HS, Novitsky TJ, Bucklin A, Kania SA, Siber GR: Endotoxin neutralization with rabbit antiscra to Escherichia coli J5 and other gram-negative bacteria. Infect Immun 1987;55:1668-1673.
22. Berger D, Bölke E, Hügel H, Seidelmann M, Hannekum A, Beger HG: New aspects concerning the regulation of the postoperative acute phase reaction during cardiac surgery. Clin Chim Acta 1995:239:121-130.
23. Andersen LW, Back L, Degn H, Lehd J, Krasnik M, Rasmussen JP: Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 1987;93:115-119.
24. Rocke DA, Gaffin SL, Wells MT, Koen Y, Brock-Utine JG: Endotox-entia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987;93:832-837.
25. Nilsson L, Kulander L, Nyström SO, Eriksson O: Endotoxins in cardiopulmonary bypass. J Thorac Car-diovascSurg 1990;100:777-780.
26. Imura K, Fukui Y, Yagi M, et al: Perioperative change of plasma endotoxin levels in early infants. J Pe-diatrSurg 1989:24:1232-1235.
27. Bucller HR, ten Cate JW, Sturk A, Thomas LL: Validity of the endotoxin assay in postsurgical patients. Prog Clin Biol Res 1985:189:405-417.
28. Hiki N, Berger D, Buttcnschoen K, et al: Endotoxcmia and specific anti-body behaviour against different endotoxins following multiple injury. J Trauma 1995;38:794-801.
29. Berger D. Schleich S. Seidelmann M, Beger HG: Correlation between endotoxin-neutralizing capacity of human plasma as tested by the limulus amebocytc lysate test and plasma protein levels. FEBS Lett 1990:277: 33-36.
30. Martinez-Pellus AE, Merino P, Bru M. et al: Can selective digestive decontamination avoid the endotoxcmia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med 1993;21:1684-1691.
31. Andersen LW, Baek L, Thomsen BS, Rasmussen JP: Effect of methyl-prednisolone on endotoxcmia and complement activation during cardiac surgery. J Cardiothorac Vase Anesth 1989;3:544-549.
32. Karlstad MD, Patteson SK, Guszeza JA, Iangdon Rm Chcsney JT: Mcth-ylprednisolonc does not influence endotoxin translocation during cardiopulmonary bypass. J Cardiothorac Vase Anesth 1993;7:23-27.
33. Inaba H, Kochi A, Yorozu S: Suppression by methylprednisotone of augmented plasma endotoxin-like activity and interleukin-6 during cardiopulmonary bypass. Br J Anaesth 1994;72:348-350.
34. Taggart DP, Sundaram S, McCartney C, et al: Endotoxemia, complement. and white blood cell activation in cardiac surgery: A randomized trial of laxatives and pulsatile perfusion. Ann Thorac Surg 1994; 57:376-382.
35. Watarida S, Mori Am Onoc M, et al: A clinical study on the effects of pulsatile cardiopulmonary bypass on the blood endotoxin levels. J Thorac Cardiovasc Surg 1994; 108:620-625.
36. Frering Bm Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM: Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;108:636-641.
37. Calvano SE, Thompson WA, Marra MN, et al: Changes in polymorphonuclear leukocyte surface and plasma bactcricidal/permeability-in-creasing protein and plasma lipo-polysaccharidc binding protein during endotoxcmia or sepsis. Arch Surg 1994:129:220-226.
38. Opal SM, Palardy JE, Marra MN, Fisher CJJ. McKelligon BM, Scott RW: Relative concentrations of endotoxin-binding proteins in body fluids during infection. Lancet 1994: 344:429-431.